Tobacco company Philip Morris’ purchase of a health and wellness company must be scrutinised as “the potential consequence of this is giving access to regulatory and policy making spaces within the health sector,” says Professor Sarah Hawkes (UCL Institute of Global Health).
Read: Telegraph (£)
Close
